Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis

BACKGROUND: Patient‐reported outcome (PRO) measures historically used in inflammatory bowel disease have been considered inadequate to support future drug labelling claims by regulatory agencies. AIMS: To develop PRO tools for use in Crohn's disease (CD) and ulcerative colitis (UC) following gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulai, Parambir S., Jairath, Vipul, Khanna, Reena, Ma, Christopher, McCarrier, Kelly P., Martin, Mona L., Parker, Claire E., Morris, Joan, Feagan, Brian G., Sandborn, William J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Symptoms and Impacts Questionnaire for Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317756/
https://www.ncbi.nlm.nih.gov/pubmed/32319120
http://dx.doi.org/10.1111/apt.15726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317756/
https://www.ncbi.nlm.nih.gov/pubmed/32319120
http://dx.doi.org/10.1111/apt.15726

Ejemplares similares